{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:27:00Z","timestamp":1793028420470,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Urology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ajur.2023.01.008","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T06:53:13Z","timestamp":1681368793000},"page":"246-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Proposal for pathogenesis-based treatment options to reduce calcium oxalate stone recurrence"],"prefix":"10.1016","volume":"10","author":[{"given":"Saeed R.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin K.","family":"Canales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajur.2023.01.008_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41581-020-00392-1","article-title":"Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation","volume":"17","author":"Khan","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajur.2023.01.008_bib2","article-title":"Kidney stones","volume":"2","author":"Khan","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ajur.2023.01.008_bib3","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1681\/ASN.2014060631","article-title":"A nomogram for the prediction of kidney stone recurrence","volume":"25","author":"Eisner","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajur.2023.01.008_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11892-007-0075-6","article-title":"Diabetes and nephrolithiasis","volume":"7","author":"Daudon","year":"2007","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.ajur.2023.01.008_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ajh.2007.62","article-title":"The association of nephrolithiasis with hypertension and obesity: a review","volume":"21","author":"Obligado","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajur.2023.01.008_bib6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/j.ajkd.2007.12.030","article-title":"Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition examination Survey (NHANES III) 1988\u22121994","volume":"51","author":"West","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajur.2023.01.008_bib7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.juro.2014.05.117","article-title":"Risk of chronic and end stage kidney disease in patients with nephrolithiasis","volume":"192","author":"Shoag","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ki.1978.53","article-title":"Physicochemical aspects of urolithiasis","volume":"13","author":"Finlayson","year":"1978","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ki.1994.341","article-title":"Calcium oxalate nephrolithiasis, a free or fixed particle disease","volume":"46","author":"Kok","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib10","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.2741\/1347","article-title":"Modulators of urinary stone formation","volume":"9","author":"Khan","year":"2004","journal-title":"Front Biosci"},{"key":"10.1016\/j.ajur.2023.01.008_bib11","first-page":"442","article-title":"The expectation of free and fixed particles in urinary stone disease","volume":"15","author":"Finlayson","year":"1978","journal-title":"Invest Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00240-016-0942-1","article-title":"Physicochemical mechanisms of stone formation","volume":"45","author":"Rodgers","year":"2017","journal-title":"Urolithiasis"},{"key":"10.1016\/j.ajur.2023.01.008_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/bju.12481","article-title":"Urinary saturation: casual or causal risk factor in urolithiasis?","volume":"114","author":"Rodgers","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.ki.5000238","article-title":"Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis","volume":"69","author":"Evan","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib15","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1089\/end.2021.0685","article-title":"Stone morphology distinguishes two pathways of idiopathic calcium oxalate stone pathogenesis","volume":"36","author":"Williams","year":"2022","journal-title":"J Endourol"},{"key":"10.1016\/j.ajur.2023.01.008_bib16","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.juro.2011.10.125","article-title":"Association of Randall plaque with collagen fibers and membrane vesicles","volume":"187","author":"Khan","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.ki.5002569","article-title":"Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients","volume":"72","author":"Evan","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jtemb.2011.05.004","article-title":"High Zn content of Randall's plaque: a \u03bc-X-ray fluorescence investigation","volume":"25","author":"Carpentier","year":"2011","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.ajur.2023.01.008_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0090-4295(84)90021-9","article-title":"Renal papillary changes in patient with calcium oxalate lithiasis","volume":"23","author":"Khan","year":"1984","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2023.01.008_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1681\/ASN.2015111271","article-title":"Genome-wide gene expression profiling of Randall's plaques in calcium oxalate stone formers","volume":"28","author":"Taguchi","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajur.2023.01.008_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep35167","article-title":"M1\/M2-macrophage phenotypes regulate renal calcium oxalate crystal development","volume":"6","author":"Taguchi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajur.2023.01.008_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1089\/end.2017.0699","article-title":"Inflammatory cytokines in the papillary tips and\u00a0urine\u00a0of\u00a0nephrolithiasis patients","volume":"32","author":"Sun","year":"2018","journal-title":"J Endourol"},{"key":"10.1016\/j.ajur.2023.01.008_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00240-010-0296-z","article-title":"Plaque and deposits in nine human stone diseases","volume":"38","author":"Coe","year":"2010","journal-title":"Urol Res"},{"key":"10.1016\/j.ajur.2023.01.008_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00240-017-1031-9","article-title":"High frequency and wide range of human kidney papillary crystalline plugs","volume":"46","author":"Huguet","year":"2018","journal-title":"Urolithiasis"},{"key":"10.1016\/j.ajur.2023.01.008_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002239900140","article-title":"Lipids and membranes in the organic matrix of urinary calcific crystals and stones","volume":"59","author":"Khan","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12953-016-0093-x","article-title":"Label-free proteomic methodology for the analysis of human kidney stone matrix composition","volume":"14","author":"Witzmann","year":"2016","journal-title":"Proteome Sci"},{"key":"10.1016\/j.ajur.2023.01.008_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2010.05.005","article-title":"Proteome of human calcium kidney stones","volume":"76","author":"Canales","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2023.01.008_bib28","doi-asserted-by":"crossref","first-page":"F1254","DOI":"10.1152\/ajprenal.00134.2008","article-title":"Proteomic analysis of renal calculi indicates\u00a0an important role for inflammatory processes in\u00a0calcium\u00a0stone formation","volume":"295","author":"Merchant","year":"2008","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ajur.2023.01.008_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068624","article-title":"Diversity in protein profiles of individual calcium oxalate kidney stones","volume":"8","author":"Okumura","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajur.2023.01.008_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cca.2013.11.036","article-title":"Inflammatory and fibrotic proteins proteomically identified as key protein constituents in urine and stone matrix of patients with kidney calculi","volume":"429","author":"Boonla","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajur.2023.01.008_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-5347(17)35454-X","article-title":"Role of organic matrix in urinary stone formation: an ultrastructural study of crystal matrix interface of calcium oxalate monohydrate stones","volume":"150","author":"Khan","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02556340","article-title":"Presence of lipids in urinary stones: results of preliminary studies","volume":"42","author":"Khan","year":"1988","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib33","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/jbmr.5650101211","article-title":"Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi","volume":"10","author":"McKee","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajur.2023.01.008_bib34","first-page":"e86","article-title":"Kidney stones: a global picture of prevalence, incidence, and associated risk factors","volume":"12","author":"Romero","year":"2010","journal-title":"Rev Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib35","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.juro.2006.10.069","article-title":"Changing gender prevalence of stone disease","volume":"177","author":"Scales","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib36","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00345-022-04060-w","article-title":"Urinary stone composition in Germany: results from 45 783 stone analyses","volume":"40","author":"Siener","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib37","doi-asserted-by":"crossref","first-page":"e781","DOI":"10.1016\/j.ijrobp.2011.11.024","article-title":"Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999\u20132007","volume":"82","author":"Dinan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ajur.2023.01.008_bib38","first-page":"171","article-title":"Risk factors for renal calcium stone formation in South African and European young adults","volume":"81","author":"Rodgers","year":"2009","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.ajur.2023.01.008_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00240-012-0516-9","article-title":"Race, ethnicity and urolithiasis: a critical review","volume":"41","author":"Rodgers","year":"2013","journal-title":"Urolithiasis"},{"key":"10.1016\/j.ajur.2023.01.008_bib40","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1046\/j.1523-1755.2003.00917.x","article-title":"Time trends in reported prevalence of kidney stones in the United States: 1976\u20131994","volume":"63","author":"Stamatelou","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib41","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/ndt\/16.11.2232","article-title":"Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study","volume":"16","author":"Strazzullo","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ajur.2023.01.008_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ejhg.2012.139","article-title":"Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies","volume":"21","author":"Beck","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ajur.2023.01.008_bib43","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.juro.2015.10.001","article-title":"Coronary artery calcium score and association with recurrent nephrolithiasis: the multi-ethnic study of atherosclerosis","volume":"195","author":"Hsi","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.ajkd.2014.03.017","article-title":"Kidney stones and cardiovascular risk: a meta-analysis of cohort studies","volume":"64","author":"Liu","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajur.2023.01.008_bib45","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.2013.8780","article-title":"History of kidney stones and the risk of coronary heart disease","volume":"310","author":"Ferraro","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ajur.2023.01.008_bib46","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3390\/nu13061917","article-title":"Nutrition and kidney stone disease","volume":"13","author":"Siener","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ajur.2023.01.008_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2215\/CJN.09200721","article-title":"Temporal trends of dietary risk factors after a diagnosis of kidney stones","volume":"17","author":"Ferraro","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ajur.2023.01.008_bib48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/nu13010062","article-title":"Contribution of dietary oxalate and oxalate precursors to urinary oxalate excretion","volume":"13","author":"Crivelli","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ajur.2023.01.008_bib49","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/nu12020548","article-title":"Calcium oxalate nephrolithiasis and gut microbiota: not just a gut-kidney axis. A nutritional perspective","volume":"12","author":"Ticinesi","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ajur.2023.01.008_bib50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jn\/116.3.455","article-title":"Oxalate degradation by gastrointestinal bacteria from humans","volume":"116","author":"Allison","year":"1986","journal-title":"J Nutr"},{"issue":"Suppl. 14","key":"10.1016\/j.ajur.2023.01.008_bib51","first-page":"S334","article-title":"Direct correlation between hyperoxaluria\/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy","volume":"10","author":"Sidhu","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajur.2023.01.008_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/bju.14840","article-title":"Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study","volume":"125","author":"Tavasoli","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib53","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.kint.2019.02.012","article-title":"Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis","volume":"96","author":"Miller","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00240-017-0998-6","article-title":"A randomised Phase II\/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria","volume":"46","author":"Milliner","year":"2018","journal-title":"Urolithiasis"},{"key":"10.1016\/j.ajur.2023.01.008_bib55","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41585-022-00647-5","article-title":"Mechanisms of the intestinal and urinary microbiome in kidney stone disease","volume":"19","author":"Miller","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1210\/jcem-71-4-861","article-title":"The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men","volume":"71","author":"Kok","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajur.2023.01.008_bib57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/ajkd.2002.34504","article-title":"Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism","volume":"40","author":"Reddy","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajur.2023.01.008_bib58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/ajcn\/69.2.267","article-title":"Acute effects of moderate dietary\u00a0protein\u00a0restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis","volume":"69","author":"Giannini","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajur.2023.01.008_bib59","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3945\/ajcn.2009.28614","article-title":"Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial","volume":"91","author":"Nouvenne","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajur.2023.01.008_bib60","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.juro.2013.03.074","article-title":"Dietary calcium from dairy and nondairy sources, and risk of symptomatic kidney stones","volume":"190","author":"Taylor","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib61","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.HYP.0000053450.19998.11","article-title":"DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity","volume":"41","author":"Lopes","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ajur.2023.01.008_bib62","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1681\/ASN.2009030276","article-title":"DASH-style diet associates with reduced risk for kidney stones","volume":"20","author":"Taylor","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajur.2023.01.008_bib63","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1089\/end.2011.0130","article-title":"Antioxidants and self-reported history of kidney stones: the National Health and Nutrition Examination Survey","volume":"25","author":"Holoch","year":"2011","journal-title":"J Endourol"},{"key":"10.1016\/j.ajur.2023.01.008_bib64","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5551\/jat.RV17020","article-title":"Plaque calcification during atherosclerosis progression and regression","volume":"25","author":"Shioi","year":"2018","journal-title":"J Atherosclerosis Thromb"},{"key":"10.1016\/j.ajur.2023.01.008_bib65","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.redox.2017.12.003","article-title":"Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line","volume":"15","author":"Patel","year":"2018","journal-title":"Redox Biol"},{"key":"10.1016\/j.ajur.2023.01.008_bib66","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.freeradbiomed.2012.01.005","article-title":"Mitochondrial permeability transition pore opening induces the initial process of renal calcium crystallization","volume":"52","author":"Niimi","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ajur.2023.01.008_bib67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urology.2018.01.029","article-title":"Impact of statin intake on kidney stone formation","volume":"124","author":"Cohen","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2023.01.008_bib68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12967-019-1821-7","article-title":"Testosterone induces renal tubular epithelial cell death through the HIF-1\u03b1\/BNIP3 pathway","volume":"17","author":"Peng","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajur.2023.01.008_bib69","article-title":"Relationship between serum testosterone levels and kidney stones prevalence in men","volume":"13","author":"Huang","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ajur.2023.01.008_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00240-010-0276-3","article-title":"An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors","volume":"39","author":"Shakhssalim","year":"2011","journal-title":"Urol Res"},{"key":"10.1016\/j.ajur.2023.01.008_bib71","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.juro.2010.08.009","article-title":"Testosterone and androgen receptor in human nephrolithiasis","volume":"184","author":"Li","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib72","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/03915603211017885","article-title":"CAG repeats and one polymorphism in androgen receptor gene are associated with renal calcium stone disease","volume":"89","author":"Basiri","year":"2022","journal-title":"Urologia"},{"key":"10.1016\/j.ajur.2023.01.008_bib73","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/MOU.0000000000001051","article-title":"Role of microbiome in kidney stone disease","volume":"33","author":"Gal\u00e1n-Llopis","year":"2023","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib74","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12866-020-01734-6","article-title":"Profiling the urinary microbiome in men with calcium-based kidney stones","volume":"20","author":"Xie","year":"2020","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ajur.2023.01.008_bib75","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00240-022-01314-5","article-title":"Comparative functional analysis of the urinary tract microbiome for individuals with or without calcium oxalate calculi","volume":"50","author":"Kachroo","year":"2022","journal-title":"Urolithiasis"},{"key":"10.1016\/j.ajur.2023.01.008_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.953392","article-title":"Urinary microbial and metabolomic profiles in kidney stone disease","volume":"12","author":"Gao","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ajur.2023.01.008_bib77","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00240-010-0303-4","article-title":"Nephrocalcinosis in animal models with and without stones","volume":"38","author":"Khan","year":"2010","journal-title":"Urol Res"},{"key":"10.1016\/j.ajur.2023.01.008_bib78","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF01367661","article-title":"Animal models of kidney stone formation: an analysis","volume":"15","author":"Khan","year":"1997","journal-title":"World J Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib79","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/sj.ki.5001699","article-title":"Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline","volume":"70","author":"Khan","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib80","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/ndt\/gfr035","article-title":"Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats","volume":"26","author":"Zuo","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ajur.2023.01.008_bib81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1464-410X.2005.05579.x","article-title":"Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status","volume":"96","author":"Thamilselvan","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib82","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/S0022-5347(05)65042-2","article-title":"Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol","volume":"167","author":"Huang","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib83","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.ASN.0000113321.49771.2D","article-title":"Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys","volume":"15","author":"Umekawa","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajur.2023.01.008_bib84","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00240-011-0370-1","article-title":"Why does atorvastatin inhibit renal crystal retention?","volume":"39","author":"Tsujihata","year":"2011","journal-title":"Urol Res"},{"key":"10.1016\/j.ajur.2023.01.008_bib85","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/eji.200940168","article-title":"Signaling by ROS drives inflammasome activation","volume":"40","author":"Martinon","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ajur.2023.01.008_bib86","article-title":"Role of ROS-induced NLRP3 inflammasome activation in the formation\u00a0of calcium oxalate nephrolithiasis","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajur.2023.01.008_bib87","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI63679","article-title":"Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1beta secretion","volume":"123","author":"Mulay","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajur.2023.01.008_bib88","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ki.2013.207","article-title":"NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy","volume":"84","author":"Knauf","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib89","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.juro.2014.11.093","article-title":"Activation of the NLRP3 inflammasome in association with calcium oxalate crystal induced reactive oxygen species in kidneys","volume":"193","author":"Joshi","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib90","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/iub.2250","article-title":"Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4\/NF-kappaB and NLRP3 inflammasome","volume":"72","author":"Sun","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ajur.2023.01.008_bib91","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1210\/me.2014-1047","article-title":"Androgen receptor enhances kidney stone-CaOx crystal formation via modulation of oxalate biosynthesis & oxidative stress","volume":"28","author":"Liang","year":"2014","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ajur.2023.01.008_bib92","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41419-019-1358-y","article-title":"Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment\/M2 polarization with change of the miR-185-5p\/CSF-1 signals","volume":"10","author":"Zhu","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajur.2023.01.008_bib93","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.kint.2017.09.022","article-title":"The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury","volume":"93","author":"Anders","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib94","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1681\/ASN.2017101148","article-title":"ABCC6 deficiency promotes development of Randall plaque","volume":"29","author":"Letavernier","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajur.2023.01.008_bib95","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/BJ20041465","article-title":"Oxalate-inducible AMBP gene and its regulatory mechanism in renal tubular epithelial cells","volume":"387","author":"Grewal","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.ajur.2023.01.008_bib96","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/jbmr.158","article-title":"Renal macrophage migration and crystal phagocytosis via inflammatory-related gene expression during kidney stone formation and elimination in mice: detection by association analysis of stone-related gene expression and microstructural observation","volume":"25","author":"Okada","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajur.2023.01.008_bib97","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10157-004-0292-0","article-title":"Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies","volume":"8","author":"Khan","year":"2004","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ajur.2023.01.008_bib98","doi-asserted-by":"crossref","first-page":"F1285","DOI":"10.1152\/ajprenal.00057.2014","article-title":"Regulation of macromolecular modulators of urinary stone formation by reactive oxygen species: transcriptional study in an animal model of hyperoxaluria","volume":"306","author":"Khan","year":"2014","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ajur.2023.01.008_bib99","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.bbadis.2015.06.020","article-title":"Osteogenic changes in kidneys of hyperoxaluric rats","volume":"1852","author":"Joshi","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajur.2023.01.008_bib100","doi-asserted-by":"crossref","first-page":"F1935","DOI":"10.1152\/ajprenal.00383.2007","article-title":"Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both","volume":"293","author":"Mo","year":"2007","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ajur.2023.01.008_bib101","doi-asserted-by":"crossref","first-page":"F469","DOI":"10.1152\/ajprenal.00243.2010","article-title":"Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein","volume":"299","author":"Liu","year":"2010","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ajur.2023.01.008_bib102","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ndt\/gfh750","article-title":"Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate\u00a0and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells","volume":"20","author":"Umekawa","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ajur.2023.01.008_bib103","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.bios.2009.12.013","article-title":"Effect of calcium oxalate on renal cells as revealed by real-time measurement of extracellular oxidative burst","volume":"25","author":"Gaspar","year":"2010","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.ajur.2023.01.008_bib104","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00240-005-0492-4","article-title":"Hyperoxaluria-induced oxidative stress and antioxidants for renal protection","volume":"33","author":"Khan","year":"2005","journal-title":"Urol Res"},{"key":"10.1016\/j.ajur.2023.01.008_bib105","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.freeradbiomed.2005.02.020","article-title":"Crystal and microparticle effects on MDCK cell superoxide production: oxalate-specific mitochondrial membrane potential changes","volume":"38","author":"Meimaridou","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ajur.2023.01.008_bib106","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/ndt\/gfq692","article-title":"Temporal changes in the expression of mRNA of NADPH oxidase subunits in renal epithelial cells exposed to oxalate or calcium oxalate crystals","volume":"26","author":"Khan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ajur.2023.01.008_bib107","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.ki.5001651","article-title":"Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors","volume":"70","author":"Huang","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib108","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00240-005-0007-3","article-title":"Reactive oxygen species mediated calcium oxalate crystal-induced expression of MCP-1 in HK-2 cells","volume":"34","author":"Habibzadegah-Tari","year":"2006","journal-title":"Urol Res"},{"key":"10.1016\/j.ajur.2023.01.008_bib109","doi-asserted-by":"crossref","first-page":"F1399","DOI":"10.1152\/ajprenal.00051.2009","article-title":"Oxalate-induced activation of PKC-alpha and -delta regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cells","volume":"297","author":"Thamilselvan","year":"2009","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ajur.2023.01.008_bib110","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1111\/j.1523-1755.2004.00963.x","article-title":"Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity","volume":"66","author":"Cao","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajur.2023.01.008_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093056","article-title":"C-phycocyanin confers protection against oxalate-mediated oxidative stress and mitochondrial dysfunctions in MDCK cells","volume":"9","author":"Farooq","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajur.2023.01.008_bib112","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7528090","article-title":"MitoTEMPO prevents oxalate induced injury in NRK-52E cells via inhibiting mitochondrial dysfunction and modulating oxidative stress","volume":"2017","author":"Zhang","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ajur.2023.01.008_bib113","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.juro.2015.11.048","article-title":"Calcium oxalate stone fragment and crystal phagocytosis by human macrophages","volume":"195","author":"Kusmartsev","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2023.01.008_bib114","doi-asserted-by":"crossref","first-page":"11463","DOI":"10.1002\/jcp.27803","article-title":"Sirtuin 3 suppresses the formation of renal calcium oxalate crystals through promoting M2 polarization of macrophages","volume":"234","author":"Xi","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ajur.2023.01.008_bib115","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1002\/jcb.28109","article-title":"SIRT3 inhibited the formation of calcium oxalate-induced kidney stones through regulating NRF2\/HO-1 signaling pathway","volume":"120","author":"Xi","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ajur.2023.01.008_bib116","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00240-011-0448-9","article-title":"Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?","volume":"40","author":"Khan","year":"2012","journal-title":"Urol Res"},{"key":"10.1016\/j.ajur.2023.01.008_bib117","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/CIRCRESAHA.116.310262","article-title":"Human alternative macrophages populate calcified areas of atherosclerotic lesions and display impaired RANKL-induced osteoclastic bone resorption activity","volume":"121","author":"Chinetti-Gbaguidi","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.ajur.2023.01.008_bib118","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.matbio.2015.01.015","article-title":"Metalloproteinases promote plaque rupture and myocardial infarction: a persuasive concept waiting for clinical translation","volume":"44\u20136","author":"Newby","year":"2015","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ajur.2023.01.008_bib119","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8836355","article-title":"The activation of ROS\/NF-kappaB\/MMP-9 pathway promotes calcium-induced kidney crystal deposition","volume":"2021","author":"Wu","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ajur.2023.01.008_bib120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MOL.0000000000000111","article-title":"Proteinases and plaque rupture: unblocking\u00a0the\u00a0road to translation","volume":"25","author":"Newby","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ajur.2023.01.008_bib121","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/462361","article-title":"NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys","volume":"2013","author":"Joshi","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ajur.2023.01.008_bib122","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological inhibitors of the NLRP3 inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajur.2023.01.008_bib123","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi therapeutic for primary\u00a0hyperoxaluria type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajur.2023.01.008_bib124","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/1874467212666181127151059","article-title":"Mitochondria-targeted drugs","volume":"12","author":"Zinovkin","year":"2019","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.ajur.2023.01.008_bib125","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00467-018-4005-4","article-title":"Oxidative stress in chronic kidney disease","volume":"34","author":"Daenen","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ajur.2023.01.008_bib126","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.phymed.2018.08.002","article-title":"The natural phenolic compounds as modulators of NADPH oxidases in hypertension","volume":"55","author":"Yousefian","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ajur.2023.01.008_bib127","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a beta-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajur.2023.01.008_bib128","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cca.2019.10.034","article-title":"Macrophage polarization in atherosclerosis","volume":"501","author":"Yang","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajur.2023.01.008_bib129","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2795090","article-title":"The reactive oxygen species in macrophage polarization: reflecting its dual role in progression and treatment of human diseases","volume":"2016","author":"Tan","year":"2016","journal-title":"Oxid Med Cell Longev"}],"container-title":["Asian Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221438822300036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221438822300036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:44:07Z","timestamp":1729039447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221438822300036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":129,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S221438822300036X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajur.2023.01.008","relation":{},"ISSN":["2214-3882"],"issn-type":[{"value":"2214-3882","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proposal for pathogenesis-based treatment options to reduce calcium oxalate stone recurrence","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajur.2023.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}